SCHEMBL3105380

SCHEMBL3105380

O=C(O)c1ccc2oc3ccc(Cl)cc3c2c1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 8/20 0.84
ALDH1A1 P00352 4/20 0.57
MCL1 Q07820 1/20 0.57
AHR P35869 2/20 0.55
KDM4E B2RXH2 4/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
HPGD P15428 3/20 0.49
HSD17B10 Q99714 3/20 0.49
SRD5A2 P31213 2/20 0.47
SRD5A1 P18405 1/20 0.47
AKR1B1 P15121 1/20 0.47
TP53 P04637 1/20 0.46
CYP2C9 P11712 1/20 0.46
PTGER1 P34995 1/20 0.46
PTGER3 P43115 1/20 0.46
PTGER2 P43116 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL71110 0.89 TTR (0.68) TTRALDH1A1KDM4EMEN1KMT2A
SCHEMBL11859810 0.84 TTR (0.89) TTRALDH1A1MCL1AHRKDM4E
SCHEMBL14039696 0.84 TTR (0.62) TTRALDH1A1MCL1AHRKDM4E
SCHEMBL11768568 0.81 TTR (0.65) TTRALDH1A1KDM4EMEN1KMT2A
SCHEMBL2282515 0.80 AHR (0.78) TTRALDH1A1MCL1AHRKDM4E
SCHEMBL9471701 0.80 TTR (0.57) TTRALDH1A1AHRKDM4EMEN1
SCHEMBL1222307 0.80 TTR (0.78) TTRALDH1A1KDM4EMEN1KMT2A
SCHEMBL68189 0.79 TTR (0.83) TTRALDH1A1KDM4EMEN1KMT2A
Hydrochloric Acid SCHEMBL11749391 0.78 TTR (0.81) TTRALDH1A1KDM4EMEN1KMT2A
SCHEMBL11865210 0.77 TTR (0.80) TTRALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056600-A1 11BETA-HSD1 ACTIVE COMPOUNDS HIGH POINT PHARMACEUTICALS, LLC 2010-03-04 US claimed
US-20100056600-A1 11BETA-HSD1 ACTIVE COMPOUNDS HIGH POINT PHARMACEUTICALS, LLC 2010-03-04 US disclosed
EP-2141990-A1 11BETA-HSD1 ACTIVE COMPOUNDS High Point Pharmaceuticals, LLC (US) 2010-01-13 EP disclosed
WO-2008119017-A1 11BETA-HSD1 ACTIVE COMPOUNDS HIGH POINT PHARMACEUTICALS, LLC (US) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056600-A1 11BETA-HSD1 ACTIVE COMPOUNDS HSD11B1, HSD3B1, HSD11B2 TTR 2383/4885ALDH1A1 111/4885MCL1 3744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.